Filings
Finds words inside filing documents. Searching Jasper Therapeutics, Inc.'s filings · 64 documents indexed.
11 documents · 77 matches
-
JSPR Jasper Therapeutics, Inc. 10-Q 2026-08-14
Item 1 · Note 2. Summary of Significant Accounting Policies
Going Concern, the Company evaluated whether there are conditions and events, considered in the aggregate, that raise substantial doubt about11 matches in this document -
JSPR Jasper Therapeutics, Inc. 10-Q 2026-05-14
Item 1 · Note 2. Summary of Significant Accounting Policies
Going Concern, the Company evaluated whether there are conditions and events, considered in the aggregate, that raise substantial doubt about11 matches in this document -
JSPR Jasper Therapeutics, Inc. 10-K 2026-03-30
Item 8 · Note 2. Summary of Significant Accounting Policies
Going Concern, the Company evaluated whether there are conditions and events, considered in the aggregate, that raise substantial doubt about15 matches in this document -
JSPR Jasper Therapeutics, Inc. 10-Q 2025-11-10
Item 1 · Note 2. Summary of Significant Accounting Policies
Going Concern, the Company evaluated whether there are conditions and events, considered in the aggregate, that raise substantial doubt about9 matches in this document -
JSPR Jasper Therapeutics, Inc. 10-Q 2025-08-13
Item 1 · Note 2. Summary of Significant Accounting Policies
Going Concern, the Company evaluated whether there are conditions and events, considered in the aggregate, that raise substantial doubt about8 matches in this document -
JSPR Jasper Therapeutics, Inc. 10-Q 2025-05-12
Item 1 · Note 2. Summary of Significant Accounting Policies
Going Concern, the Company evaluated whether there are conditions and events, considered in the aggregate, that raise substantial doubt about8 matches in this document -
JSPR Jasper Therapeutics, Inc. 8-K/A 2026-10-01
going concern. As discussed in Note 1 to the consolidated financial statements, the Company has incurred losses since inception and has an accumulated8 matches in this document -
JSPR Jasper Therapeutics, Inc. 8-K/A 2026-10-01
1. Nature of Business, Basis of Presentation and Going Concern4 matches in this document -
JSPR Jasper Therapeutics, Inc. 8-K 2026-06-01
going concern and its imminent need to raise additional funding to continue its operations; risks related to Jasper’s ability1 match in this document -
JSPR Jasper Therapeutics, Inc. 8-K 2026-05-14
going concern and its imminent need to raise additional funding to continue its operations; the risk that Jasper may be unable1 match in this document -
JSPR Jasper Therapeutics, Inc. 8-K 2026-03-30
going concern and the risk that Jasper may be unable to raise capital to continue its operations and continue its Phase1 match in this document
Page 1 of 1 · 11 documents